What does CUSIP 90041T108 represent in this 13F holders report?

CUSIP 90041T108 is the security identifier for TPTX - TURNING POINT THERAPEUTICS I - COM used to aggregate holder disclosures.

How many institutions held TPTX - TURNING POINT THERAPEUTICS I - COM in Q2 2019?

69 institutional investors reported TPTX - TURNING POINT THERAPEUTICS I - COM for Q2 2019. Use the holders table for investor-level position and value details.

TURNING POINT THERAPEUTICS I - COM (TPTX)

CUSIP: 90041T108

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / COM
Total 13F shares: 18,229,128
Share change: +18,228,986
Total reported value: $741,919,938
Price per share: $40.70
Number of holders: 69
Value change: +$741,914,148
Number of buys: 68

Quarterly Holders Quick Answers

What is CUSIP 90041T108?
CUSIP 90041T108 identifies TPTX - TURNING POINT THERAPEUTICS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019

Recent filing periods for CUSIP 90041T108:

Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020

Institutional Holders of TURNING POINT THERAPEUTICS I - COM (TPTX) as of Q2 2019

As of 30 Jun 2019, TURNING POINT THERAPEUTICS I - COM (TPTX) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,229,128 shares. The largest 10 holders included Cormorant Asset Management, LP, FMR LLC, ORBIMED ADVISORS LLC, Foresite Capital Management IV, LLC, venBio Partners LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, and PERCEPTIVE ADVISORS LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.